Updates on triple-negative breast cancer and immunotherapy
Updates on triple-negative breast cancer and immunotherapy
Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA
Predictive and prognostic biomarkers for immunotherapy in lung cancer
Gynaecological cancer: New targets and immunotherapy developments
Molecular oncology and translational medicine
Adjuvant nivolumab vs placebo in resected oesophageal or gastroesophageal junction cancer following chemo: Biomarker analysis
Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC
Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer
Botensilimab plus balstilimab for metastatic heavily pretreated microsatellite stable colorectal cancer
Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma
The role of the workforce in implementing Choosing Wisely in cancer care
The role of provider assumptions in decreasing access to care in the LGBTQ community